Free Float 25,28 %
Shares Float 1,1 M
Shares Outstanding 4,34 M
Monterey Bio Acquisition Corporation Share · US61240F1084 · MTRY (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Monterey Bio Acquisition Corporation
No Price
Share Float & Liquidity
Company Profile for Monterey Bio Acquisition Corporation Share
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Company Data
Name Monterey Bio Acquisition Corporation
Company Monterey Bio Acquisition Corporation
Symbol MTRY
Website
https://www.montereybio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US61240F1084
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Murat Omur
Market Capitalization 48 Mio
Country United States of America
Currency USD
Employees -
Address 17 State Street, 10004 New York City
IPO Date 2021-11-22
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | MTRY |
More Shares
Investors who hold Monterey Bio Acquisition Corporation also have the following shares in their portfolio:
